Cortrophin Demand Is Soaring For ANI Pharma, CEO Says Well-Positioned To Mitigate Potential Tariff Impact

benzinga.com/general/health-care/25/05/45323449/cortrophin-demand-is-soaring-for-ani-pharma-ceo-says-well-positioned-to-mitigate-potential-ta

ANI Pharmaceuticals Inc (NASDAQ:ANIP) reported first-quarter adjusted earnings of $1.70 per share on Friday, up from $1.21 a year ago, beating the consensus of $1.38 per share.
The company reported sales of $197.12 million, up 43.4% year over year, beating the consensus of $180.68…

This story appeared on benzinga.com, 2025-05-09 16:07:00.
The Entire Business World on a Single Page. Free to Use →